JP2009511469A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009511469A5 JP2009511469A5 JP2008534487A JP2008534487A JP2009511469A5 JP 2009511469 A5 JP2009511469 A5 JP 2009511469A5 JP 2008534487 A JP2008534487 A JP 2008534487A JP 2008534487 A JP2008534487 A JP 2008534487A JP 2009511469 A5 JP2009511469 A5 JP 2009511469A5
- Authority
- JP
- Japan
- Prior art keywords
- probiotic
- group
- reduce
- pharmaceuticals
- probiotic bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 claims 16
- 239000000047 product Substances 0.000 claims 16
- 239000006041 probiotic Substances 0.000 claims 15
- 230000000529 probiotic effect Effects 0.000 claims 15
- 235000018291 probiotics Nutrition 0.000 claims 15
- 244000199866 Lactobacillus casei Species 0.000 claims 7
- 235000013958 Lactobacillus casei Nutrition 0.000 claims 7
- 229940017800 lactobacillus casei Drugs 0.000 claims 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims 6
- 230000036186 satiety Effects 0.000 claims 6
- 235000019627 satiety Nutrition 0.000 claims 6
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims 5
- 229940009289 bifidobacterium lactis Drugs 0.000 claims 5
- 235000015872 dietary supplement Nutrition 0.000 claims 5
- 235000013305 food Nutrition 0.000 claims 5
- 235000016709 nutrition Nutrition 0.000 claims 5
- 208000008589 Obesity Diseases 0.000 claims 4
- 210000000579 abdominal fat Anatomy 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 235000020824 obesity Nutrition 0.000 claims 4
- 102000004877 Insulin Human genes 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 238000009825 accumulation Methods 0.000 claims 3
- 235000019577 caloric intake Nutrition 0.000 claims 3
- 235000013339 cereals Nutrition 0.000 claims 3
- 235000013399 edible fruits Nutrition 0.000 claims 3
- 235000012631 food intake Nutrition 0.000 claims 3
- 230000037406 food intake Effects 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 229940125396 insulin Drugs 0.000 claims 3
- 235000013336 milk Nutrition 0.000 claims 3
- 239000008267 milk Substances 0.000 claims 3
- 210000004080 milk Anatomy 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 241000186000 Bifidobacterium Species 0.000 claims 2
- 102100024650 Carbonic anhydrase 3 Human genes 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 230000003828 downregulation Effects 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 230000004584 weight gain Effects 0.000 claims 2
- 235000019786 weight gain Nutrition 0.000 claims 2
- 101150020529 APOA4 gene Proteins 0.000 claims 1
- 102000011690 Adiponectin Human genes 0.000 claims 1
- 108010076365 Adiponectin Proteins 0.000 claims 1
- 102100037320 Apolipoprotein A-IV Human genes 0.000 claims 1
- 101710167915 Carbonic anhydrase 3 Proteins 0.000 claims 1
- 102000003706 Complement factor D Human genes 0.000 claims 1
- 108090000059 Complement factor D Proteins 0.000 claims 1
- 101000760630 Homo sapiens Carbonic anhydrase 3 Proteins 0.000 claims 1
- 101100301584 Mus musculus Retnlb gene Proteins 0.000 claims 1
- 102100037861 Resistin-like beta Human genes 0.000 claims 1
- 101710133220 Resistin-like beta Proteins 0.000 claims 1
- 101150097713 SCD1 gene Proteins 0.000 claims 1
- 101150071549 Thrsp gene Proteins 0.000 claims 1
- 108010073614 apolipoprotein A-IV Proteins 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- -1 natural remedies Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0502214A SE529185C2 (sv) | 2005-10-07 | 2005-10-07 | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
| PCT/SE2006/001117 WO2007043933A1 (en) | 2005-10-07 | 2006-10-02 | Probiotics to influence fat metabolism and obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009511469A JP2009511469A (ja) | 2009-03-19 |
| JP2009511469A5 true JP2009511469A5 (https=) | 2009-11-19 |
Family
ID=37943064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008534487A Pending JP2009511469A (ja) | 2005-10-07 | 2006-10-02 | 脂肪代謝及び肥満に影響を及ぼすプロバイオティクス |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080267933A1 (https=) |
| EP (2) | EP1945235B1 (https=) |
| JP (1) | JP2009511469A (https=) |
| CN (1) | CN101287478B (https=) |
| AU (1) | AU2006299956B2 (https=) |
| BR (1) | BRPI0616993A2 (https=) |
| CA (1) | CA2624890A1 (https=) |
| CY (1) | CY1113704T1 (https=) |
| DK (2) | DK2431044T3 (https=) |
| EA (1) | EA015461B1 (https=) |
| ES (2) | ES2396865T3 (https=) |
| PL (1) | PL1945235T3 (https=) |
| PT (1) | PT1945235E (https=) |
| SE (1) | SE529185C2 (https=) |
| SI (1) | SI1945235T1 (https=) |
| WO (1) | WO2007043933A1 (https=) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007085970A2 (en) * | 2006-01-27 | 2007-08-02 | Danisco A/S | Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
| JP5229977B2 (ja) * | 2006-09-08 | 2013-07-03 | 雪印メグミルク株式会社 | 血中アディポネクチン濃度増加促進及び／又は減少抑制剤 |
| US9084434B2 (en) * | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| EP2011506A1 (en) | 2007-07-05 | 2009-01-07 | Nestec S.A. | Supplementation of maternal diet |
| BRPI0721863A2 (pt) * | 2007-07-25 | 2014-02-18 | Danisco | Composição para induzir ou melhorar a sensação de satisfação e/ou saciedade, método para identificar e/ou isolar bactérias que são capazes de induzir ou melhorar satisfação e/ou saciedade, cepa bacteriana, uso de uma cepa bacteriana, e, método para preparar um alimento, suplemento alimentício ou composição alimetícia que melhora satisfação e/ou saciedade. |
| EP2030623A1 (en) * | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| JP5225652B2 (ja) * | 2007-10-29 | 2013-07-03 | 雪印メグミルク株式会社 | アディポネクチン分泌促進及び／又は減少抑制剤 |
| AU2008333718B2 (en) | 2007-12-06 | 2012-03-15 | Arla Foods Amba | Probiotic bacteria and regulation of fat storage |
| FR2930264B1 (fr) * | 2008-04-18 | 2013-02-22 | Gervais Danone Sa | Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices. |
| EP2123168B1 (en) * | 2008-05-16 | 2011-12-21 | Nestec S.A. | Lactobacillus paracasei and weight control |
| WO2009142713A1 (en) * | 2008-05-19 | 2009-11-26 | Nestec S.A. | Methods for reducing lipid absorption by an animal |
| AU2009282482B2 (en) * | 2008-08-15 | 2015-11-26 | Société des Produits Nestlé S.A. | Methods for enhancing energy metabolism |
| FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
| CA2753083C (en) * | 2009-03-06 | 2021-04-20 | Federation Des Producteurs Acericoles Du Quebec | Symbiotic maple product compositions and methods |
| EP2407170B1 (en) * | 2009-03-10 | 2015-03-25 | Jinis Biopharmaceuticals Co. | Prevention and treatment of obesity and metabolic diseases induced by obesity using microorganisms |
| US20120027737A1 (en) | 2009-03-25 | 2012-02-02 | Chr-Hansen A/S | Use of probiotics to ameliorate diet-induced insulin resistance |
| DK2411027T3 (en) * | 2009-03-25 | 2015-01-19 | Chr Hansen As | USING a probiotic ADJUSTING body weight |
| WO2010114864A1 (en) * | 2009-04-01 | 2010-10-07 | Little Calumet Holdings, Llc | Probiotic oral dosage forms |
| FI123157B (fi) * | 2009-05-12 | 2012-11-30 | Valio Oy | Probioottien uusi käyttö |
| EP3181134B1 (en) | 2009-06-19 | 2019-10-30 | DuPont Nutrition Biosciences ApS | Bifidobacteria for treating diabetes and related conditions |
| JP5436991B2 (ja) * | 2009-09-10 | 2014-03-05 | 国立大学法人北海道大学 | ラクトバチルス・プランタラムの菌体又は培養物を有効成分とするインスリン抵抗性改善剤 |
| EP2308499A1 (en) * | 2009-09-30 | 2011-04-13 | Nestec S.A. | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| CN107574131A (zh) | 2009-11-11 | 2018-01-12 | 营养健康有限公司 | 益生菌双歧杆菌菌株 |
| FR2955774A1 (fr) | 2010-02-02 | 2011-08-05 | Aragan | Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation |
| NL2004200C2 (en) | 2010-02-05 | 2011-08-08 | Friesland Brands Bv | Use of sialyl oligosaccharides in weight management. |
| KR101873193B1 (ko) * | 2010-06-08 | 2018-07-02 | 아사히 그룹 홀딩스 가부시키가이샤 | 지질 대사 개선제 |
| ES2389547B1 (es) * | 2010-12-07 | 2013-08-08 | Consejo Superior De Investigaciones Científicas (Csic) | Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas. |
| US11523934B2 (en) | 2011-02-04 | 2022-12-13 | Seed Health, Inc. | Method and system to facilitate the growth of desired bacteria in a human's mouth |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US9987224B2 (en) | 2011-02-04 | 2018-06-05 | Joseph E. Kovarik | Method and system for preventing migraine headaches, cluster headaches and dizziness |
| US10687975B2 (en) | 2011-02-04 | 2020-06-23 | Joseph E. Kovarik | Method and system to facilitate the growth of desired bacteria in a human's mouth |
| US10842834B2 (en) | 2016-01-06 | 2020-11-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
| US12533312B2 (en) | 2011-02-04 | 2026-01-27 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11273187B2 (en) | 2015-11-30 | 2022-03-15 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing depression in an individual |
| US10086018B2 (en) | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| US10548761B2 (en) | 2011-02-04 | 2020-02-04 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| US11419903B2 (en) | 2015-11-30 | 2022-08-23 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US10245288B2 (en) | 2011-02-04 | 2019-04-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US10512661B2 (en) | 2011-02-04 | 2019-12-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
| ITMI20111488A1 (it) | 2011-08-03 | 2013-02-04 | Gnosis Spa | Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita' |
| US9636367B2 (en) * | 2011-10-18 | 2017-05-02 | Nestec S.A. | Composition for use in increasing insulin sensitivity and/or reducing insulin resistance |
| EP2925333A1 (en) | 2012-11-12 | 2015-10-07 | Compagnie Gervais Danone | Lactobacillus rhamnosus strain for reducing body fat accumulation |
| MY183171A (en) * | 2013-04-17 | 2021-02-18 | Suntory Holdings Ltd | Composition containing bacterium belonging to genus lactobacillus |
| ES2526986B1 (es) | 2013-07-18 | 2015-11-02 | Biopolis, S.L. | Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas |
| KR101535077B1 (ko) * | 2013-09-13 | 2015-07-08 | 주식회사한국야쿠르트 | 인슐린 저항성 개선 효능을 가지는 비피도박테리움 락티스 hy8101 및 이를 유효성분으로 함유하는 제품 |
| KR101545551B1 (ko) | 2013-12-12 | 2015-08-19 | 주식회사한국야쿠르트 | 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물 |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| WO2015121458A2 (fr) * | 2014-02-14 | 2015-08-20 | Vesale Pharma Sa | Composition comprenant du bifidobacterium animalis ssp. lactis |
| US20160354418A1 (en) * | 2014-02-14 | 2016-12-08 | Vesale Pharma Sa | Use of compositions comprising bifidobacterium animalis ssp. lactis lmg p-28149 |
| BE1000016B1 (fr) * | 2014-04-25 | 2016-02-01 | Vesale Pharma Nv | Composition comprenant du bifidobacterium animalis ssp. lactis. |
| WO2015121455A1 (fr) * | 2014-02-14 | 2015-08-20 | Vesale Pharma Sa | Composition comprenant au moins un probiotique |
| BE1000017B1 (fr) * | 2014-04-25 | 2016-01-21 | Vesale Pharma Nv | Composition comprenant au moins un probiotique |
| MX2017001734A (es) * | 2014-08-08 | 2017-04-27 | Nestec Sa | Mioinositol y probioticos y usos. |
| CN104186655B (zh) * | 2014-08-27 | 2016-06-29 | 内蒙古伊利实业集团股份有限公司 | 具有降血脂及抗氧化功能的低脂发酵乳及其制备方法 |
| KR101604212B1 (ko) * | 2015-07-17 | 2016-03-17 | 울산대학교 산학협력단 | Ｎａｄ를 함유하는 비만 또는 내당능장애의 예방 및 치료용 조성물 |
| US12239706B2 (en) | 2015-11-30 | 2025-03-04 | Seed Health, Inc. | Method and system for protecting monarch butterflies from pesticides |
| CN109312297B (zh) * | 2015-12-11 | 2022-09-23 | 精密生物集团有限公司 | 用于治疗肥胖症和相关代谢病的干酪乳杆菌 |
| KR20220001516A (ko) * | 2016-04-14 | 2022-01-05 | 듀폰 뉴트리션 바이오사이언시즈 에이피에스 | 식품, 에너지 및/또는 지방 섭취 감소를 위한 비피더스균 |
| CN109089421A (zh) | 2017-02-10 | 2018-12-25 | 完美（中国）有限公司 | 新型双歧杆菌益生菌菌株 |
| US10695386B2 (en) | 2017-05-11 | 2020-06-30 | Shayne K. Morris | Skin microbiome colonizer formulations and methods for use |
| TWI640313B (zh) * | 2017-08-18 | 2018-11-11 | 長庚生物科技股份有限公司 | 戈氏副擬桿菌用於抑制肥胖之用途 |
| US11168299B2 (en) | 2018-04-11 | 2021-11-09 | Shayne Morris | Pairing probiotics and prebiotics, methods for growth and use, separately and in combination |
| US11291696B2 (en) | 2018-04-11 | 2022-04-05 | Shayne Morris | Pairing probiotics and prebiotics, methods for growth and use, separately and in combination |
| US12150967B2 (en) | 2018-08-18 | 2024-11-26 | Seed Health, Inc. | Methods and compositions for honey bee health |
| FR3095761B1 (fr) | 2019-05-06 | 2023-11-10 | Lab Attitude | Composition nutraceutique pour induire une perte de poids et réduire la graisse abdominale |
| AU2020412749A1 (en) | 2019-12-27 | 2022-06-16 | Biopolis, S.L. | Uses of lipoteichoic acid from Bifidobacteria |
| CN111587952A (zh) * | 2020-05-27 | 2020-08-28 | 佛山科学技术学院 | 一种降低家犬体脂沉积的益生菌添加剂 |
| JP7718672B2 (ja) * | 2020-12-25 | 2025-08-05 | 日清食品株式会社 | 腸溶コーティング錠 |
| KR102616412B1 (ko) * | 2021-07-30 | 2023-12-21 | 주식회사 메디오젠 | 비피도박테리움 애니말리스 락티스 mg741 균주를 포함하는 비만 또는 비알콜성 지방간 예방 또는 치료용 조성물 |
| FR3125945B1 (fr) | 2021-08-03 | 2024-07-12 | Setalg | Composition pour protéger un microorganisme dans un environnement acide. |
| KR102445708B1 (ko) | 2021-12-02 | 2022-09-23 | 일동바이오사이언스(주) | 비피도박테리움 락티스 idcc 4301을 포함하는 체지방감소용 조성물 |
| CN118716406A (zh) * | 2024-04-30 | 2024-10-01 | 卡士乳业(深圳)有限公司 | 含活性乳双歧杆菌的发酵乳在调节亚健康人群状态中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61109729A (ja) * | 1984-11-05 | 1986-05-28 | Advance Res & Dev Co Ltd | コレステロ−ル低下剤 |
| JPS61271223A (ja) * | 1985-05-24 | 1986-12-01 | Biofuerumin Seiyaku Kk | 血中脂質改善剤 |
| JPH0696537B2 (ja) * | 1986-05-02 | 1994-11-30 | 雪印乳業株式会社 | 血清コレステロ−ル上昇抑制剤 |
| JP2992945B2 (ja) * | 1994-03-11 | 1999-12-20 | カルピス株式会社 | ラクトバチルス・アシドフィルス乳酸菌 |
| JPH107577A (ja) * | 1996-06-17 | 1998-01-13 | Yakult Honsha Co Ltd | 血糖降下剤 |
| SE510813C2 (sv) * | 1997-12-08 | 1999-06-28 | Arla Ekonomisk Foerening | Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen |
| US6641808B1 (en) | 1999-09-22 | 2003-11-04 | Lacpro Industries, Llc | Composition for treatment of obesity |
| US6696057B1 (en) | 1999-09-22 | 2004-02-24 | Lacpro Industries, Inc. | Composition and method for treatment of gastrointestinal disorders and hyperlipidemia |
| JP2001097870A (ja) * | 1999-09-30 | 2001-04-10 | Snow Brand Milk Prod Co Ltd | 乳酸菌を利用した胆汁酸の吸着方法 |
| JP2001292728A (ja) | 2000-04-13 | 2001-10-23 | Enajikku Kk | 肥満防止食品 |
| JP4580542B2 (ja) * | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
| US6383482B1 (en) * | 2000-08-24 | 2002-05-07 | Vitacost.Com, Inc. | Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus |
| US6963306B2 (en) * | 2001-02-02 | 2005-11-08 | Rosum Corp. | Position location and data transmission using pseudo digital television transmitters |
| EP1344458A1 (en) * | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
| US6565847B1 (en) | 2002-07-03 | 2003-05-20 | Vitacost.Com, Inc. | Thermogenic weight management composition |
| US20040014403A1 (en) * | 2002-07-16 | 2004-01-22 | Oberkampf Brandon L. | CMP point of use filtration |
| US6942857B2 (en) * | 2002-08-09 | 2005-09-13 | Bioneer Corporation | Microorganisms for preventing and/or treating obesity or diabetes mellitus |
| US20070098705A1 (en) * | 2003-05-22 | 2007-05-03 | Symbiotics Ab | Probiotic composition comprising at least two lactic acid bacterial strains which are able to clonise the gatrointestonal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and fiber fermenting property |
| SE0400355D0 (sv) * | 2004-02-17 | 2004-02-17 | Synbiotics Ab | New synbiotec use |
| US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
| AU2008333718B2 (en) * | 2007-12-06 | 2012-03-15 | Arla Foods Amba | Probiotic bacteria and regulation of fat storage |
-
2005
- 2005-10-07 SE SE0502214A patent/SE529185C2/sv not_active IP Right Cessation
-
2006
- 2006-10-02 CA CA002624890A patent/CA2624890A1/en not_active Abandoned
- 2006-10-02 AU AU2006299956A patent/AU2006299956B2/en not_active Ceased
- 2006-10-02 SI SI200631495T patent/SI1945235T1/sl unknown
- 2006-10-02 CN CN2006800368040A patent/CN101287478B/zh active Active
- 2006-10-02 DK DK11191774.6T patent/DK2431044T3/en active
- 2006-10-02 ES ES06799717T patent/ES2396865T3/es active Active
- 2006-10-02 EP EP06799717A patent/EP1945235B1/en active Active
- 2006-10-02 WO PCT/SE2006/001117 patent/WO2007043933A1/en not_active Ceased
- 2006-10-02 EA EA200800913A patent/EA015461B1/ru not_active IP Right Cessation
- 2006-10-02 US US12/089,433 patent/US20080267933A1/en not_active Abandoned
- 2006-10-02 PL PL06799717T patent/PL1945235T3/pl unknown
- 2006-10-02 ES ES11191774.6T patent/ES2567404T3/es active Active
- 2006-10-02 DK DK06799717.1T patent/DK1945235T3/da active
- 2006-10-02 PT PT67997171T patent/PT1945235E/pt unknown
- 2006-10-02 BR BRPI0616993-7A patent/BRPI0616993A2/pt not_active IP Right Cessation
- 2006-10-02 JP JP2008534487A patent/JP2009511469A/ja active Pending
- 2006-10-02 EP EP11191774.6A patent/EP2431044B1/en not_active Revoked
-
2012
- 2012-12-27 CY CY20121101262T patent/CY1113704T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009511469A5 (https=) | ||
| EP2431044B1 (en) | Probiotics to influence fat metabolism and obesity | |
| Kalantzopoulos | Fermented products with probiotic qualities | |
| Mombelli et al. | The use of probiotics in medical practice | |
| TWI574633B (zh) | 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物 | |
| JP4777365B2 (ja) | プロバイオティクスおよび単離されたβ−グルカンを含有する食物ならびにその使用方法 | |
| US10543239B2 (en) | Lactic acid bacteria and bifidobacteria for treating endotoxemia | |
| EP2216036A1 (en) | Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control | |
| JP2008214253A (ja) | 内臓脂肪減少剤 | |
| JP2002537865A5 (https=) | ||
| CN108029923A (zh) | 一种具有抗过敏效果的益生菌固体饮料生产配方 | |
| KR20140026326A (ko) | 신장 기능을 강화시키는 조성물 및 방법 | |
| Mahasneh et al. | Probiotics and traditional fermented foods: The eternal connection (Mini-Review) | |
| JP2005532294A (ja) | 腎機能を増強するための組成物及び方法 | |
| Nagpal et al. | Probiotics, prebiotics and synbiotics: An introduction | |
| JP5209294B2 (ja) | インターロイキン１２産生促進剤 | |
| CN103918795A (zh) | 一种茶多酚益生菌羊奶片及其制备方法 | |
| WO2017009188A1 (en) | Lactobacilli for treating cardiac dysfunction | |
| Khan et al. | Probiotic: A Sustainable Approach towards Healthy Food | |
| JP2024046233A (ja) | 腸管バリアの改善のための組成物 | |
| MX2008004578A (en) | Probiotics to influence fat metabolism and obesity |